$RKLB

Cantor sees Rocket Lab stock as good entry point after Iridium funding

Cantor Fitzgerald maintains a bullish outlook on Rocket Lab (RKLB) after it secured funding for its Iridium acquisition. The deal, expected to close in mid-2027, aims to double combined revenue. Iridium reported $850M revenue in FY2025, with shares up 164% over the past year. Rocket Lab targets its first Neutron rocket launch this year, with Cantor modeling $900M revenue for FY2026.

Original reporting
Published Sep 21, 2026, 12:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 21, 2026, 12:37 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefMergers & acquisitions
Primary signal
$RKLB
Bullish
high confidence
Mentioned
$RKLB · $IRDM
Relevance
7/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$RKLBBullishMed
01

Why it matters

The funding announcement removes a major financing uncertainty, likely prompting short‑term buying pressure on both RKLB and IRDM as the market prices in the pending merger.

02

Market read

The news provides a fresh catalyst for both stocks, offering a potential entry point for traders.

03

What to watch

Potential regulatory scrutiny and financing costs if market conditions shift.

Relevance 7/10Novelty 7/10Timing: today

Background

Cantor Fitzgerald reiterates a bullish stance on Rocket Lab after the company announced it secured sufficient cash to fund its Iridium acquisition, with the deal expected to close mid‑2027.

Company-level read

Ticker impact

$RKLBBullishHigh confidence
Context

Rocket Lab secured funding to complete its pending acquisition of Iridium Communications, a fresh primary disclosure.

Expected impact

Potential upside of 5‑10% as investors price in the completed acquisition.

Evidence & confidence

The acquisition is material for RKLB and the funding news is new, giving traders a clear catalyst.

$IRDMBullishHigh confidence
Context

Iridium is the target of Rocket Lab's acquisition; the deal funding and credit amendment are newly disclosed.

Expected impact

Potential upside of 4‑8% as the market digests the merger progress.

Evidence & confidence

The credit amendment and funding announcement are fresh facts that affect IRDM valuation.

Market effects

Strengthens the small‑sat launch sector and may boost related launch service providers.

Positive for U.S. aerospace and satellite communications markets.

Highlights continued consolidation in the space launch industry worldwide.

Counterpoint

Deal execution risk remains; integration challenges could pressure the combined entity.

Key entities

  • Rocket Lab USA, Inc.

    U.S. aerospace launch provider acquiring Iridium.

  • Iridium Communications Inc.

    Satellite communications firm being acquired.

Related articles

$RKLBHigh

RKLB Stock Price Forecast – Why Raymond James Is Betting Big on Rocket Lab

Rocket Lab USA (RKLB) shares rose 2% pre-market after Raymond James initiated coverage with an Outperform rating and $80 price target, citing growth potential. The company completed its 16th Electron launch in 2026, deploying a satellite. Analyst Brian Gesuale highlights RKLB's vertical integration and expects positive EBITDA by 2027/2028, though notes integration risks from acquisitions.

$RKLBLowAI 9/10

Los Angeles Aerospace Manufacturing: Supply Chain Opportunities

Los Angeles County is seeing a surge in aerospace and defense contracts, totaling $7B in the past six months. Major recipients include Rocket Lab, Northrop Grumman, Caltech, SpaceX, Teledyne Technologies, and Canopy Aerospace. This boom creates opportunities for suppliers, as primes seek reliable, certified partners. The region's concentration of aerospace firms and talent pool positions it uniquely for growth.

$RKLBHighAI 8/10

Rocket Lab Stock Reverses 4.8%; Iridium’s FCC Review Is Only Starting

Rocket Lab (RKLB) shares fell 4.79% to $64.57 on Friday, after a 6.48% gain the previous day. The company raised $1.944 billion via a share offering, with 29.3 million new shares issued. The decline comes as the FCC begins its review of Rocket Lab's acquisition of Iridium (IRDM), with comments due by October 15. Iridium's shareholders will vote on the deal on September 24. Analysts have set price targets for RKLB ranging from $80 to $122.

$ASTSMedAI 8/10

ASTS, RKLB Stocks Sink To Multi-Month Lows While SPCX Holds Steady – Piper Sandler Says Elon Musk’s Company Is Yet To Prove Itself

AST SpaceMobile (ASTS) and Rocket Lab (RKLB) shares fell 15% and 10% respectively, while SpaceX (SPCX) held steady. Piper Sandler initiated coverage, rating ASTS 'Overweight' with a $100 target, RKLB 'Neutral' with an $83 target, and SPCX 'Neutral' with a $156 target. ASTS priced a $1B convertible note offering.

$RKLBMed

RocketLab Stock Down Overnight, But CEO Says SpaceX IPO Helped As 90th Electron Launch Nears: ‘Clear Number Two’

Rocket Lab USA (RKLB) shares fell 2% overnight after a 7% rise on Monday. The company prepared for its 90th Electron launch, with CEO Peter Beck affirming its position as the 'clear number two' behind SpaceX. Beck noted SpaceX's IPO has drawn investor interest to the space sector, benefiting Rocket Lab. RKLB stock has surged 330% over the past year, with bullish retail sentiment on Stocktwits.